Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution while Breastfeeding

What is Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution used for?

Can I continue breastfeeding if I am using Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution? How long does it stays in breast milk?

Sulfacetamide sodium while Breastfeeding

CAS Number: 144-80-9

A short-term action Sulfonamide which is similar to Sulfathiazole (see specific info) that is locally used on vagina, eyes and skin. At latest update relevant published data were not found on excretion into breast milk. Because of the small dose used and poor absorption into plasma of most topical preparations for dermatological and ophthalmological issues, it is unlikely a significant excretion into breast milk. As with other sulfonamides, caution is recommended when using it on preterm infants and newborns with hyperbilirubinemia. Avoid it on patients affected with deficit of Glucose 6-Phosphate Dehydrogenase (6-GPD). Monitor the appearance of jaundice in the infant.

Prednisolone sodium phosphate while Breastfeeding

CAS Number: 50-24-8

Excreted into breast milk in non-significant amount with no problems reported in breastfed infants whose mothers were treated at a daily dose as high as 7.5 mg for a long time period. At a daily dose of 60 mg used for treatment of Herpes or Gestational Pemphigus no harm effects on breastfed infants have been reported. On long term treatments it would be advisable to wait for 3 - 4 hours until the next nurse to minimize the transfer of drug to breast milk. At high doses, intra-articular treatment with other steroid drugs (Triamcinolone) have transiently affected milk production. Steroids administered before delivery may delay initiation of phase II of Lactogenesis ("milk come in") and decrease milk production in the first postpartum week. Decreased production has been seen while taking Dexametasone. Steroid drugs are commonly used for Pediatric treatment with no side effects when infrequently used and for short-time periods. The American Academy of Pediatrics rates it compatible with breastfeeding. WHO Model List of Essential Medicines (2002) rates it compatible with breastfeeding

Prednisolone sodium phosphate while Breastfeeding

CAS Number: 50-24-8

Amounts of prednisolone in breastmilk are very low. No adverse effect have been reported in breastfed infants with maternal use of any corticosteroid during breastfeeding. With high maternal doses, avoiding breastfeeding for 4 hours after a dose should markedly decrease the dose received by the infant. However, this maneuver is not necessary with short-term use. High doses might occasionally cause temporary loss of milk supply. Because absorption from the eye is limited, ophthalmic prednisolone would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

What should I do if I am breastfeeding mother and I am already exposed to Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution?

My doctor has prescribed me Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution, what should I do?

If I am using Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Sulfacetamide Sodium And Prednisolone Sodium Phosphate Solution in breastfeeding?